AA amyloidosis: basic knowledge, unmet needs and future treatments
about
Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damageMonoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitorsAmyloidosis in a Captive Zebra Finch (Taeniopygia guttata) Research ColonyChronic renal failure due to amyloid nephropathy caused by chronic infection after total hip replacement.Outcome of 121 patients with renal amyloid a amyloidosis.Protein profiling of isolated uterine AA amyloidosis causing fetal death in goats.Intestinal Amyloidosis in Common Variable Immunodeficiency and Rheumatoid Arthritis.Electron tomography reveals the fibril structure and lipid interactions in amyloid deposits.Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartanPutative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.Systemic Amyloid A Amyloidosis in Island Foxes (Urocyon littoralis): Severity and Risk Factors.Serum amyloid A renal amyloidosis in a chronic subcutaneous ("skin popping") heroin user.Up-regulation of MUC2 mucin expression by serum amyloid A3 protein in mouse colonic epithelial cells.Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis.Serum amyloid A induces mitogenic signals in regulatory T cells via monocyte activation.The N-terminal region of serum amyloid A3 protein activates NF-κB and up-regulates MUC2 mucin mRNA expression in mouse colonic epithelial cellsSerum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis.Inhibitory effect of propolis on the development of AA amyloidosis.Novel Therapies in Light Chain Amyloidosis.
P2860
Q26770744-052F9D47-170C-4DD5-8511-20D3F9D56AABQ26824970-98A77A4F-8591-4DA4-AE75-4E9725A3802DQ28601268-B202D7C0-20DA-42E4-BB6C-73A3A50954E8Q33622192-152BA467-3284-4CD8-A8E9-F86E2070A15AQ34425496-1C44101D-2628-45EF-874F-62CB8618AC04Q35448094-939B67D6-D9E8-4FB8-9C6F-E8CF892E8007Q36006210-E943EF63-929C-43D4-A1C4-9DBCF98F243EQ36007352-F1DB6A11-6593-4CBF-A299-ACDB05ADDA0CQ36167581-A3655BDD-8A86-43B5-99C5-939CDFCB0EFFQ36207025-66F54549-CAC0-4040-8160-4730237C1129Q36913150-284DAF2C-BEC9-4629-B820-CA0F08A5D2D3Q37476117-D64FE834-8173-429A-B924-87E03C232E7FQ39008807-02B77328-2DC6-40C6-81E7-826187F89745Q40316884-6A861535-A3AC-4968-A8BB-2030785C86D9Q41072807-B0FF6CCD-8E23-46BB-B33F-16806F962082Q41105625-5A7FBBA2-6F6F-47EC-8C1D-901C6585FEE9Q48028286-7C2F0FB6-29D1-46B5-A455-0F1117CB5D69Q54082926-17D3A2E3-1047-4D23-9D49-5A61DDE04B47Q55127439-77845EE3-667A-4A4C-BCCE-2173A6623E0E
P2860
AA amyloidosis: basic knowledge, unmet needs and future treatments
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
AA amyloidosis: basic knowledge, unmet needs and future treatments
@ast
AA amyloidosis: basic knowledge, unmet needs and future treatments
@en
AA amyloidosis: basic knowledge, unmet needs and future treatments
@nl
type
label
AA amyloidosis: basic knowledge, unmet needs and future treatments
@ast
AA amyloidosis: basic knowledge, unmet needs and future treatments
@en
AA amyloidosis: basic knowledge, unmet needs and future treatments
@nl
prefLabel
AA amyloidosis: basic knowledge, unmet needs and future treatments
@ast
AA amyloidosis: basic knowledge, unmet needs and future treatments
@en
AA amyloidosis: basic knowledge, unmet needs and future treatments
@nl
P356
P1433
P1476
AA amyloidosis: basic knowledge, unmet needs and future treatments
@en
P2093
P304
P356
10.4414/SMW.2012.13580
P407
P577
2012-05-31T00:00:00Z